Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer.
Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer.
复制标题
Enah 过度表达与胃癌的不良生存率和侵袭性表型相关
DOI:
10.1038/s41419-018-1031-x
复制
发表时间:
2018-09-24
影响因子:
9
通讯作者:
Ren G
中科院分区:
文献类型:
--
作者:
Chen D;Xu L;Li X;Chu Y;Jiang M;Xu B;Zhao M;Wang W;Wang H;Kang H;Wang K;Wu K;Liang J;Ren G
Enabled homolog (Enah), which is a member of the Ena/VASP family that also includes VASP (vasodilator-stimulated phosphoprotein) and Ena/VASP like, is a mammalian ortholog of Drosophila Enabled (Ena). An increasing number of studies demonstrated Enah overexpression is involved in human colorectal carcinomas, breast cancers and hepatocellular carcinoma. However, the significance of Enah expression in gastric cancer (GC) is poorly elucidated. Here, we demonstrate that Enah is upregulated in GC and associated with AJCC stage, depth of invasion and poor overall survival (OS). Knockdown of Enah inhibited GC cell proliferation and metastasis and vice versa. Further experiments suggested that p-Erk1/2, p-AKT, p-p65, Vimentin and Fibronectin were downregulated and E-cadherin was upregulated after Enah silencing, implicating altered functions in GC proliferation and metastasis. Thus, our study suggests that Enah is a harmful factor for GC and a novel target for GC treatment.
登录
查看更多内容
影响因子:
3.8
作者:
Junnila S;Kokkola A;Karjalainen-Lindsberg ML;Puolakkainen P;Monni O
通讯作者:
Monni O
影响因子:
4.6
作者:
Balsamo M;Mondal C;Carmona G;McClain LM;Riquelme DN;Tadros J;Ma D;Vasile E;Condeelis JS;Lauffenburger DA;Gertler FB
通讯作者:
Gertler FB
影响因子:
64.5
作者:
Gertler, FB;Niebuhr, K;Soriano, P
通讯作者:
Soriano, P
影响因子:
4.8
作者:
Barzik, M;Kotova, TI;Schafer, DA
通讯作者:
Schafer, DA
影响因子:
3.4
作者:
Hu, Kunpeng;Wang, Jiani;Xu, Lihua
通讯作者:
Xu, Lihua